Product information and disease descriptionProduct description
Phase of product development
22 evidence topics · 23 sources
Regulatory status: Submission planned; NDA filing anticipated in the first half of 2027
Launch
No evidence found.
Generalized anxiety disorder
Product information and disease descriptionProduct description
22 evidence topics · 23 sources
No evidence found.